Ausgabe 1/2018
Inhalt (9 Artikel)
Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis
Teresa Schleker, Eva-Maria Jacobsen, Benjamin Mayer, Gudrun Strauss, Klaus-Michael Debatin, Carsten Posovszky
CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
Julia Seyfarth, Heinz Ahlert, Joachim Rosenbauer, Christina Baechle, Michael Roden, Reinhard W. Holl, Ertan Mayatepek, Thomas Meissner, Marc Jacobsen
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
Kelly M. Martinovich, Nicole C. Shaw, Anthony Kicic, André Schultz, Sue Fletcher, Steve D. Wilton, Stephen M. Stick
Intrauterine growth restriction - impact on cardiovascular diseases later in life
Carlos Menendez-Castro, Wolfgang Rascher, Andrea Hartner
Anti-inflammatory monocytes—interplay of innate and adaptive immunity
Georg Varga, Dirk Foell
Precision medicine in pediatric oncology
Stefan E. G. Burdach, Mike-Andrew Westhoff, Maximilian Felix Steinhauser, Klaus-Michael Debatin
The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases
Dirk Holzinger, Dirk Foell, Christoph Kessel
Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors
Justin S. Antony, Ngadhnjim Latifi, A. K. M. Ashiqul Haque, Andrés Lamsfus-Calle, Alberto Daniel-Moreno, Sebastian Graeter, Praveen Baskaran, Petra Weinmann, Markus Mezger, Rupert Handgretinger, Michael S. D. Kormann